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Abstract: Three new cembranoids, sarcocrassocolides M–O (1–3), have been isolated 
from the soft coral Sarcophyton crassocaule. The structures of the metabolites were 
determined by extensive spectroscopic analysis. Compounds 1–3 were shown to exhibit 
moderate cytotoxicity toward a limited panel of cancer cell lines and display significant  
in vitro anti-inflammatory activity in LPS-stimulated RAW264.7 macrophage cells by 
inhibiting the expression of the iNOS protein. 
Keywords: soft coral; Sarcophyton crassocaule; cytotoxic activity; anti-inflammatory 
activity  
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1. Introduction 
Cembrane-type compounds have been found to be the important diterpenoidal constituents in 
marine coelenterates [1–8]. In the investigation of the bioactive metabolites from soft corals of 
Taiwanese waters, many bioactive cembranoids have been isolated from octocorals (Alcyonaceae) 
belonging to the genera Sinularia [9–12], Lobophytum [13,14], Sarcophyton [15–20] and 
Pachyclavularia [21]. Some of these metabolites have been shown to exhibit cytotoxic activity against 
the growth of various cancer cell lines [9,11,14–21], and/or anti-inflammatory activity [10,14].
 Our 
recent study of the chemical constituents of the Dongsha Atoll soft coral Sarcophyton crassocaule [22,23] 
has yielded cembranoids sarcocrassocolides A–L, of which some were found to exhibit significant 
cytotoxic and anti-inflammatory activities. Our continuing chemical investigation on the same 
collection of this organism, with the aim of discovering other biologically active natural products, 
again led to the isolation of three new cembranoids, sarcrocrassocolides M–O (1–3) (Chart 1). The 
structures of 1–3 were established by extensive spectroscopic analysis, including careful examination 
of 2D NMR (
1H–
1H COSY, HMQC, HMBC and NOESY) correlations. The cytotoxicity of 
compounds 1–3 against human breast carcinoma (MCF-7), human colon carcinoma (WiDr), human 
laryngeal carcinoma (HEp-2) and human medulloblastoma (Daoy) cell lines was studied, and the 
ability of 1–3 to inhibit the up-regulation of pro-inflammatory iNOS (inducible nitric oxide synthase) 
and COX-2 (cyclooxygenase-2) proteins in LPS (lipopolysaccharide)-stimulated RAW264.7 
macrophage cells was also examined. It was found that compounds 1–3 were cytotoxic towards the 
above cancer cells; 2 being the most cytotoxic. Compounds 1–3 were found to significantly inhibit the 
expression of iNOS protein. 
Chart 1. Structures of metabolites 1–3. 
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2. Results and Discussion 
The HRESIMS (m/z 429.1892 [M + Na]
+) of sarcrocrassocolide M (1) established the molecular 
formula C22H30O7, appropriate for eight degrees of unsaturation, and the IR spectrum revealed the 
presence of lactonic carbonyl (1757 cm
−1) group. The 
13C NMR and DEPT (Table 1) spectroscopic 
data showed signals of three methyls (including one acetate methyl), five sp
3 methylenes, two sp
2 
methylenes, five sp
3 methines (including four oxymethines), one sp
2 methines, one sp
3 and five sp
2 
quaternary carbons (including two ester carbonyls). The NMR signals (Table 1) observed at δC 169.1 Mar. Drugs 2012, 10                                           
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(C), 139.3 (C), 121.6 (CH2), 81.4 (CH), and 37.4 (CH), and δH 6.28, 5.63 (each, 1H, d, J = 2.0 Hz), 
4.61 (1H, t, J = 2.5 Hz), and 3.07 (1H, dt, J = 11.5, 2.5 Hz) showed the presence of an α-methylene-γ-
lactonic group by comparing with similar NMR data of known cembranoids with the same   
five-membered lactone ring [22,23].
 Signals resonating at δC 60.1 (C), 60.0 (CH) and δH 2.53 (1H, dd, 
J  = 7.0, 4.0 Hz) revealed the presence of a trisubstituted epoxide. One trisubstituted and one   
1,1-disubstituted double bond were also identified from NMR signals appearing at δC 129.4 (C),   
128.1 (CH), and δH 5.46 (1H, dd, J = 7.0, 5.5 Hz), and at δC 113.5 (CH2), 146.6 (C), δH 5.16 and 5.12 
(1H, s, each), respectively. In the 
1H–
1H COSY spectrum, it was possible to identify three different 
structural units, which were assembled with the assistance of an HMBC experiment. Key HMBC 
correlations of H3-18 to C-3, C-4 and C-5; H2-19 to C-7, C-8 and C-9; H3-20 to C-11, C-12 and C-13 
and H2-17 to C-1, C-15 and C-16 permitted the establishment of the carbon skeleton (Figure 1). 
Furthermore, the acetoxy group positioned at C-13 was confirmed from the HMBC correlations of the 
methyl protons of an acetate (δH 2.02) to the ester carbonyl carbon at δC 169.2 and the oxymethine 
signal at 77.4 (C-13, CH). The 
13C NMR signals at δC 87.1 (CH) and HRESIMS showed the presence 
of a hydroperoxy group at a methine carbon C-7 [9]. On the basis of the above analysis, the planar 
structure of 1 was established unambiguously. The relative structure of 1 was elucidated by the 
analysis of NOE correlations, as shown in Figure 2. The NOE interaction of H-1 (δ 3.07) with H-2β  
(δ 1.71), H-3 (δ 2.57) and H-11 (δ 5.46) revealed the β-orientation of H-1 and H-3. H-3 did not exhibit 
NOE correlation with H3-18 (δ 1.32, s) instead it correlated with one proton of H2-5, reflecting the 
trans stereochemistry of 3,4-epoxide. The proton H-7 (δ 4.30) showed NOE interactions with H-3, and 
both H-7 and H-11 had NOE correlations with one proton of H2-9 (δ 2.14). Thus, H-7 was placed on 
the β-face. The E geometry of the trisubstituted double bond at C-11 and C-12 was assigned from the 
NOE correlation of H3-20 (δ 1.76) with one proton of H2-10 (δ 2.40), but not with the olefinic proton 
H-11, in addition to the upper field chemical shift of C-20 (δ 14.8). H-14 (δ 4.61) exhibited NOE 
correlations with both H-13 (δ 5.40) and H3-20, but not with H-1, indicating the α-orientation of both 
H-13 and H-14. These results, together with other detailed NOE correlations of 1 (Figure 2), 
unambiguously established the structure of sarcocrassocolide M, as shown in formula 1. Therefore, the 
relative structure of compound 1 was determined. 
Figure 1. 
1H–
1H COSY and HMBC correlations for 1 and 3. 
O
O
O
HOO
O
O
O
HOO
O
O
3 1
:1H-1H COSY
:  HMBC
1
3
7
11 13
16
17 18
20
19
15
 Mar. Drugs 2012, 10                                           
 
 
620
Table 1. NMR spectropic data for sarcrocrassocolides M–O (1–3).
 
Position 
Sarcrocrassocolide M (1)  Sarcrocrassocolide N (2)  Sarcrocrassocolide O (3) 
δC, mult.
a  δH (J in Hz)
 b  δC, mult.
a  δH (J in Hz)
b  δC, mult.
c  δH (J in Hz)
 d 
1  37.4, CH  3.07, dt (11.5, 2.5)
  37.5,  CH
   3.07, brd (11.5)  41.2, CH  2.78, ddd (11.2, 4.8, 2.8) 
2 34.8,  CH2  1.87, ddd (14.5, 11.5, 4.0)  35.1, CH2  1.86, ddd (15.5, 11.5, 6.0)  33.2, CH2 1.97,  m 
    1.71, m    1.71, ddd (15.5, 6.0, 2.0)    1.64, m 
3  60.0, CH  2.53, dd (7.0, 4.0)  59.9, CH  2.59, t (6.0)  59.8, CH  2.63, dd (8.8, 4.6) 
4  60.1, C     60.9, C     60.8, C    
5 32.8,  CH2  1.98, ddd (14.0, 7.0, 3.5)  32.9, CH2 1.96,  m  32.6,  CH2 1.96,  m 
    1.46, dt (14.0, 7.0)    1.42, m    1.39, m 
6 26.2,  CH2 1.72,  m  28.6,  CH2 1.62,  m  26.4,  CH2 1.78,  m 
    1.58, m    1.43, m    1.52, m 
7  87.1, CH  4.30, t (5.5)  86.1, CH  4.38, t (5.0)  86.6, CH  4.38, t (5.2) 
8  146.6, C    147.9, C    146.3, C   
9 32.5,  CH2 2.43,  m  31.9,  CH2 2.47,  m  32.5,  CH2 2.29,  m 
    2.14, ddd (14.5, 8.0, 4.0)    2.01, m    2.21, m 
10 26.1,  CH2 2.40,  m  25.5,  CH2 2.33,  m  26.0,  CH2 2.37,  m 
    2.29,  m      2.23,  m 
11  128.1, CH  5.46, dd (7,0, 5.5)  127.4, CH  5.41, t (7.5)  128.8, CH  5.26, t (6.8) 
12  129.4, C    129.4, C    130.5, C   
13  77.4, CH  5.40, s  77.4, CH  5.39, s  44.9, CH2  2.58, brd (14.4) 
            2.32, dd (14.4, 8.0) 
14  81.4, CH  4.61, t (2.5)  81.7, CH  4.62, s  82.1, CH  4.47, dt (8.0, 4.0) 
15  139.3, C    139.3, C    138.8, C   
16  169.1, C    169.1, C    169.4, C   
17 121.6,  CH2  6.28, d (2.0)  122.0, CH2  6.30, d (2.0)  122.8, CH2  6.32, d (2.4) 
    5.63, d (2.0)    5.64, d (2.0)    5.62, d (2.4) 
18 17.5,  CH3  1.32, s  17.7, CH3  1.29, s  17.0, CH3 1.33,  s 
19 113.5,  CH2  5.16, s  111.9, CH2  5.09, s  113.8, CH2 5.17,  s 
    5.12, s    5.08, s    5.12, s 
20 14.8,  CH3  1.76, s  15.1, CH3  1.78, s  17.3, CH3 1.70,  s 
OAc 20.7,  CH3  2.02, s  20.7, CH3 2.03,  s     
  169.2, C    169.2, C       
a Spectra recorded at 125 MHz in CDCl3; 
b Spectra recorded at 500 MHz in CDCl3; 
c Spectra recorded at  
100 MHz in CDCl3;
 d Spectra recorded at 400 MHz in CDCl3.  
Compound  2 possessed the same molecular formula (C22H30O7) as that of 1, as revealed from 
HRESIMS. Furthermore, it was found that the NMR spectroscopic data of 2 (Table 1) were similar to 
those of 1. Analysis of the 2D NMR (
1H–
1H COSY, HMQC, and HMBC) correlations revealed that 
compound 2 possesses the same planar structure as that of 1. From the NOESY spectrum, it was found 
that H-7 (δ 4.38) showed a weak NOE interaction with H3-20 (1.78), but not with H-11 (δ 5.41), 
revealing the α-orientation of H-7. Further analysis of other NOE interactions revealed that 2 
possessed the same relative configurations at C-1, C-3, C-4, C-13 and C-14, as those of 1 (Figure 2). 
Therefore, 2 was found to be the C-7 epimer of 1. Mar. Drugs 2012, 10                                           
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Figure 2. Key NOESY correlations for 1 and 2. 
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Compound 3 was shown by HRESIMS to possess the molecular formula C20H28O5 (m/z 371.1835 
[M + Na]
+). The IR spectrum of 3 also revealed the presence of lactonic carbonyl (1752 cm
−1) group. 
Comparison of the 
1H and 
13C NMR data (Table1) of compounds 1 and 3 showed that the structure of 
3 should be very close to that of 1, with the exception of signals assigned to C-13, where an 
acetoxymethine (δH 5.40, 1H, s; δC 77.4) in 1 was replaced by a methylene (δH 2.58, 1H, brd, J = 14.4 Hz,  
δH 2.32, 1H, dd, J = 14.4, 8.0 Hz; δC 44.9) in 3. The planar structure of 3 was elucidated by analyzing 
the 
1H–
1H COSY and HMBC correlations (Figure 1). The relative stereochemistry of 3 was confirmed 
from the key NOESY correlations (Figure 3), and the structure of sarcocrassocolide O, as shown in 
formula 3, was established unambiguously. Thus, 3 is the 13-deacetoxy derivative of 1. 
Figure 3. Key NOESY correlations for 3. 
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Similar to sarcocrassocolides F–L [22], 1–3 should be the oxidized products of the related   
3α,4α-epoxycembranolides with 7,8-olefinic group, although we have not yet discovered the similar 
oxidation from cembranolides possessing 7,8-double bond and 3β,4β-epoxide, such as sarcocrassolide (4), 
sinularolide E (5), and 13-acetoxysarcocrassolide (6) (Chart 2), which were isolated by our previous 
study [24,25]. Mar. Drugs 2012, 10                                           
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Chart 2. Structures of compounds 4–6. 
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The cytotoxicity of compounds 1–3 against the proliferation of a limited panel of cancer cell lines, 
including Daoy, HEp-2, MCF-7 and WiDr carcinoma cell lines was evaluated. The results (Table 2) 
showed that all compounds 1–3 were found to exhibit cytotoxicity against all or part of the above 
carcinoma cell lines. In this assay, the in vitro anti-inflammatory effects of compounds 1–3 were also 
tested. The inhibition of LPS-induced up-regulation of pro-inflammatory proteins, iNOS and COX-2 in 
RAW264.7 macrophage cells was measured by immunoblot analysis (Figure 4). At a concentration of 
10 μM, compounds 1–3 were found to significantly reduce the levels of iNOS protein to 4.2 ± 1.6%, 
52.9 ± 12.8%, and 22.7 ± 2.8%, respectively, relative to the control cells stimulated with LPS only. At 
the same concentration metabolites 2 and 3 did not show activity in inhibiting the expression of the 
pro-inflammatory COX-2 expression with LPS treatment, but compound 1 could reduce the expression 
of COX-2 to 62.8 ± 22.4%. Thus, compounds 1–3 might be useful anti-inflammatory agents, while 1 is 
a promising anti-inflammatory lead compound. Compound 1 could inhibit the expression of both iNOS 
and COX-2 which might be arisen from the presence of β-hydroperoxy group at C-7 by comparison 
with compound 2. 
Figure 4. Effect of compounds 1–3 on inducible nitric oxide synthetase (iNOS) and 
cyclooxygenase-2 (COX-2) proteins expression of RAW264.7 macrophage cells by 
immunoblot analysis. (A) Immunoblots of iNOS and β-actin; (B) Immunoblots of COX-2 
and  β-actin. The values are mean ± SEM (n  = 6). Relative intensity of the 
lipopolysaccharide (LPS) alone stimulated group was taken as 100%. * Significantly 
different from LPS alone stimulated group (*P < 0.05). 
a stimulated with LPS; 
b stimulated 
with LPS in the presence of 1–3 (10 μM). 
  1b 2b 3b −a
iNOS
β-action
1b 2b 3b −a
COX-2
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Table 2. Cytotoxicity (ED50 μM) of compounds 1–3. 
Compound Daoy  HEp-2  MCF-7 WiDr 
1  6.6 ± 0.8  10.4 ±1.1  10.6 ± 0.5  >40 
2  5.2 ± 0.6  12.3 ± 1.6  10.1 ± 2.3  30.1 ± 2.8 
3  5.0 ± 0.7  12.4 ± 2.1  6.4 ± 0.5  >40 
Mitomycin-C  0.44 ± 0.06  0.30 ± 0.06  0.30 ± 0.12  0.47 ± 0.12 
3. Experimental Section 
3.1. General Experimental Procedures 
Optical rotations were measured on a JASCO P-1020 polarimeter. Ultraviolet spectra were recorded 
on a JASCO V-650 spectrophotometer. IR spectra were recorded on a JASCO FT/IR-4100 infrared 
spectrophotometer. NMR spectra were recorded on a Varian 400MR FT-NMR (or Varian Unity 
INOVA500 FT-NMR) instrument at 400 MHz (or 500 MHz) for 
1H and 100 MHz (or 125 MHz) for 
13C in CDCl3. LRMS and HRMS were obtained by ESI on a Bruker APEX II mass spectrometer. Silica 
gel (Merck, 230–400 mesh) was used for column chromatography. Precoated silica gel plates (Merck, 
Kieselgel 60 F-254, 0.2 mm) were used for analytical TLC. High-performance liquid chromatography 
was performed on a Hitachi L-7100 HPLC apparatus with a Merck Hibar Si-60 column (250 × 21 mm, 
7 μm) and on a Hitachi L-2455 HPLC apparatus with a Supelco C18 column (250 × 21.2 mm, 5 μm). 
3.2. Animal Material 
S. crassocaule (specimen No. 20070402) was collected by hand using  scuba off the coast of 
Dongsha, Taiwan, in April 2007, at a depth of 5–10 m, and stored in a freezer until extraction. A 
voucher sample was deposited at the Department of Marine Biotechnology and Resources, National 
Sun Yat-sen University. 
3.3. Extraction and Separation 
The frozen bodies of S. crassocaule (0.5 kg, wet wt.) were minced and exhaustively extracted with 
EtOAc (1 L × 5). The EtOAc extract (7.3 g) was chromatographed over silica gel by column 
chromatography and eluted with EtOAc in n-hexane (0–100%, stepwise) then with acetone in EtOAc 
(50–100%, stepwise) to yield 28 fractions. Fraction 10, eluting with n -hexane–EtOAc (6:1), was 
further purified over silica gel using n-hexane-EtOAc (7:1) to afford six subfractions (A1–A6). 
Subfraction A5 was separated by normal-phase HPLC using CH2Cl2-Acetone (40:1) to afford 3  
(2.1 mg). Fraction 14, eluting with n-hexane-EtOAc (3:1), was further purified over silica gel using  
n-hexane-acetone (5:1) to afford eight subfractions (B1–B8). Subfraction B8 was separated by C18 
column chromatography and further purified by normal-phase HPLC using CH2Cl2-Acetone (25:1) to 
afford 1 (4.6 mg). Fraction 17, eluting with n-hexane-EtOAc (1:1), was further purified over silica gel 
using n-hexane-acetone (3:1) to afford seven subfractions (C1–C7). Subfraction C7 was separated by 
reversed-phase HPLC using MeOH-H2O (7:5) to afford 2 (2.2 mg).  Mar. Drugs 2012, 10                                           
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Sarcocrassocolide M (1): colorless oil; [α]
25
D  −61 (c 0.4, CHCl3); UV (MeOH) λmax 207   
(log ε = 3.6); IR (neat) vmax 3421, 2961, 2926, 2855, 1757, 1647, 1371 and 1228 cm
–1; 
13C and
 1H 
NMR data, see Table 1; ESIMS m/z 429 [M + Na]
+ ;HRESIMS m/z 429.1892 [M + Na]
+ (calcd for 
C22H30O7Na, 429.1889). 
Sarcocrassocolide N (2): colorless oil; [α]
25
D  −153 (c 0.2, CHCl3); UV (MeOH) λmax 205   
(log ε = 3.5); IR (neat) vmax 3419, 2927, 1757, 1659, 1434, 1372, 1272 and 1227 cm
–1; 
13C and
  
1H NMR data, see Table 1; ESIMS m/z 429 [M + Na]
+ ; HRESIMS m/z 429.1886 [M + Na]
+ (calcd for 
C22H30O7Na, 429.1889). 
Sarcocrassocolide O (3): colorless oil; [α]
25
D  −140 (c 0.2, CHCl3); UV (MeOH) λmax 209   
(log ε = 3.7); IR (neat) vmax 3456, 2970, 2927, 2855, 1752, 1659, 1434, 1381, and 1271 cm
–1; 
13C and
 
1H NMR data, see Table 1; ESIMS m/z 371 [M + Na]
+ ; HRESIMS m/z 371.1835 [M + Na]
+ (calcd for 
C20H28O5Na, 371.1834). 
3.4. Cytotoxicity Testing  
Cell lines were purchased from the American Type Culture Collection (ATCC). Cytotoxicity assays 
of compounds 1–3 were performed using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide] colorimetric method [26].  
3.5. In Vitro Anti-Inflammatory Assay 
Macrophage (RAW264.7) cells were purchased from ATCC. In vitro anti-inflammatory activities of 
compounds  1–3 were measured by examining the inhibition of lipopolysaccharide (LPS) induced 
upregulation of iNOS (inducible nitric oxide synthetase) and COX-2 (cyclooxygenase-2) proteins in 
macrophages cells using western blotting analysis [27]. 
4. Conclusions 
Our investigation demonstrated that the soft coral, S.  crassocaule,  could be a good source of 
bioactive substances. The isolated compounds 1–3, in particular 1, are potentially anti-inflammatory 
and may become lead compounds in the future drug development. Also, it is noteworthy to mention 
that cembranoids 1–3 possessing an α-methylene-γ-lactonic group with a rarely found 1,1-disubstituted 
double bond at C-19/C-8 and containing a hydroperoxy group at C-7, were discovered for the first time 
from corals of this species. 
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